Trial intelligence / Profile preview

Medicago Sativa on Glucose Tolerance in Overweight Adults

NCT03714438Phase 2Completed

Sponsor
Universidad de Guadalajara
Start
Feb 2017
Primary completion
Jan 2018
Countries
1
01

Overview

Phase 2, randomised, double-blind trial (2 arms), sponsored by Universidad de Guadalajara. Primary endpoints: Fasting Plasma Glucose, 2-hour Post-load Glucose and 3 more. Started Feb 2017; status: completed.

Beyond the preview

Go deeper on NCT03714438.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03714438.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call